Kaplan–Meier survival analysis showed that GC patients with high NSUN2 expression had a lower overall survival (OS) than those with low NSUN2 expression (hazard ratio, 1.93; 95% confidence interval, 1.03–3.62; log-rank P = 0.039) (Fig. 1G). Here, NSUN2 is linked to gastric cancer.